US Stock MarketDetailed Quotes
MBOT Microbot Medical
- 0.940
- +0.010+1.11%
Trading Nov 22 12:38 ET
15.92MMarket Cap-1189P/E (TTM)
0.940High0.911Low43.20KVolume0.933Open0.930Pre Close40.22KTurnover0.26%Turnover RatioLossP/E (Static)16.93MShares2.35052wk High4.18P/B15.69MFloat Cap0.82052wk Low--Dividend TTM16.69MShs Float323999.370Historical High--Div YieldTTM3.08%Amplitude0.820Historical Low0.931Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Microbot Medical Stock Forum
BRAINTREE, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic Surgical System, today announced that it has successfully completed enrollment and follow up for all patients in its ACCESS-PVI human clinica...
Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025
Microbot Medical Inc. (Nasdaq: MBOT) has successfully completed enrollment and follow-up for all patients in its ACCESS-PVI human clinical trial for the LIBERTY® Endovascular Robotic Surgical System. The company is on track to file its 510(k) submission with the FDA by the end of 202...
Microbot Medical (MBOT.US)
Microbot Medical Announces the Successful Enrollment of 50% of the Patients in Its Pivotal Human Clinical Trial for the Liberty Endovascular Robotic Surgical System! Intends to submit to FDA for 510 (K) by EOY
Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System
·1 min ago
Microbot Medical Signs Phase 2 Collaboration Agreement With Corewell Health to Advance Remote Telesurgery Using the Liberty® Endovascular Robotic System
Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer Center
Microbot Medical Inc. (Nasdaq: MBOT) has completed the enrollment of clinical sites for its pivotal human clinical trial of the LIBERTY® Endovascular Robotic Surgical System. Memorial Sloan Kettering Cancer Center in New York City joins Brigham and Women's Hospital in Boston and Baptist Hospital of Miami as the...
No comment yet